Gregory Burshtein is Chief of R&D of Entera Bio Ltd.. Currently has a direct ownership of 101,442 shares of ENTX, which is worth approximately $199,840. The most recent transaction as insider was on Jul 16, 2025, when has been sold 26,316 shares (Ordinary Shares, par value NIS 0.0000769 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 101K
n/a 3M change
n/a 12M change
Total Value Held $199,840

Gregory Burshtein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 16 2025
BUY
Grant, award, or other acquisition
-
26,316 Added 20.6%
101,442 Ordinary Shares, par v...
GB

Gregory Burshtein

Chief of R&D
Jerusalem, L3

Track Institutional and Insider Activities on ENTX

Follow Entera Bio Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTX shares.

Notify only if

Insider Trading

Get notified when an Entera Bio Ltd. insider buys or sells ENTX shares.

Notify only if

News

Receive news related to Entera Bio Ltd.

Track Activities on ENTX